Applied Therapeutics Stock In The News

APLT Stock  USD 0.51  0  0.59%   
Our overall analysis of Applied Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Applied Therapeutics. The specific impact of Applied Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Applied Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Applied Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Applied Therapeutics Backtesting and Applied Therapeutics Hype Analysis.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Applied Therapeutics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Applied Therapeutics, Inc. Sued for Secu...
https://www.globenewswire.com/news-release/2025/02/18/3028229/3080/en/Applied-Therapeutics-Inc-Sued-for-Securities-Law-Violations-Investors-Should-Contact-Levi-Korsinsky-Before-February-18-2025-to-Discuss-Your-Rights-APLT.html
 Neutral
Macroaxis News: globenewswire.com
DEADLINE ALERT for APLT and KSPI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
https://www.globenewswire.com/news-release/2025/02/18/3028111/0/en/DEADLINE-ALERT-for-APLT-and-KSPI-The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html
 Neutral
Macroaxis News: globenewswire.com
APLT FRAUD ALERT: A Class Action has bee...
https://www.globenewswire.com/news-release/2025/02/18/3027877/0/en/APLT-FRAUD-ALERT-A-Class-Action-has-been-Filed-against-Applied-Therapeutics-for-Securities-Fraud-Contact-BFA-Law-by-Today-s-Deadline-NASDAQ-APLT.html
 Bullish
Macroaxis News: globenewswire.com
APLT DEADLINE: ROSEN, RECOGNIZED INVESTO...
https://www.globenewswire.com/news-release/2025/02/17/3027376/673/en/APLT-DEADLINE-ROSEN-RECOGNIZED-INVESTOR-COUNSEL-Encourages-Applied-Therapeutics-Inc-Investors-to-Secure-Counsel-Before-Important-February-18-Deadline-in-Securities-Class-Action-APL.html
 Neutral
Macroaxis News: globenewswire.com
APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)
https://www.globenewswire.com/news-release/2025/02/16/3026972/0/en/APLT-COURT-NEWS-Applied-Therapeutics-has-been-Sued-for-Securities-Fraud-Contact-BFA-Law-by-February-18-if-You-Lost-Money-NASDAQ-APLT.html
 Bullish
Macroaxis News: globenewswire.com
APLT 截止日期通知:享譽全球的律師事務所 ROSEN 鼓勵 Applied Therapeutics, Inc. 投資者在對 APLT 提出證券集體訴訟的重要截止日期 2 月 18 日前聘請律師
https://www.globenewswire.com/news-release/2025/02/15/3026941/673/zh-hant/APLT-%E6%88%AA%E6%AD%A2%E6%97%A5%E6%9C%9F%E9%80%9A%E7%9F%A5-%E4%BA%AB%E8%AD%BD%E5%85%A8%E7%90%83%E7%9A%84%E5%BE%8B%E5%B8%AB%E4%BA%8B%E5%8B%99%E6%89%80-ROSEN-%E9%BC%93%E5%8B%B5-Applied-Therapeutics-Inc-%E6%8A%95%E8%B3%87%E8%80%85%E5%9C%A8%E5%B0%8D-APLT-%E6%8F%90%E5%87%BA%E8%AD%89%E5%88%B8%E9%9B%86%E9%AB%94%E8%A8%B4%E8%A8%9F%E7%9A%84%E9%87%8D%E8%A6%81%E6%88%AA%E6%AD%A2%E6%97%A5%E6%9C%9F-2-%E6%9C%88-18-%E6%97%A5%E5%89%8D%E8%81%98%E8%AB%8B%E5%BE%8B%E5%B8%AB.html
 Neutral
Macroaxis News: globenewswire.com
APLT DEADLINE NOTICE: ROSEN, A GLOBALLY ...
https://www.globenewswire.com/news-release/2025/02/14/3026880/673/en/APLT-DEADLINE-NOTICE-ROSEN-A-GLOBALLY-RESPECTED-LAW-FIRM-Encourages-Applied-Therapeutics-Inc-Investors-to-Secure-Counsel-Before-Important-February-18-Deadline-in-Securities-Class-A.html
 Neutral
Macroaxis News: globenewswire.com
APLT Deadline in 4 Days: Kessler Topaz M...
https://www.globenewswire.com/news-release/2025/02/14/3026756/0/en/APLT-Deadline-in-4-Days-Kessler-Topaz-Meltzer-Check-LLP-Reminds-Applied-Therapeutics-Inc-APLT-Investors-of-Filing-Deadline-in-Class-Action-Lawsuit.html
 Neutral
Macroaxis News: globenewswire.com
APLT SHAREHOLDER ACTION: Applied Therape...
https://www.globenewswire.com/news-release/2025/02/14/3026661/0/en/APLT-SHAREHOLDER-ACTION-Applied-Therapeutics-80-Stock-Drop-Prompts-Class-Action-Contact-BFA-Law-by-February-18-if-You-Suffered-Losses-NASDAQ-APLT.html
 Bullish
Macroaxis News: globenewswire.com
Applied Therapeutics, Inc. Investors: Pl...
https://www.globenewswire.com/news-release/2025/02/13/3026253/0/en/Applied-Therapeutics-Inc-Investors-Please-contact-the-Portnoy-Law-Firm-to-recover-your-losses-February-18-2025-Deadline-to-file-Lead-Plaintiff-Motion.html
 Neutral

Applied Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Applied and other traded companies coverage with news coverage. We help investors stay connected with Applied headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Applied Stock performance. Please note that trading solely based on the Applied Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Applied Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Applied Therapeutics investors visualize upcoming and past events in order to time the market based on Applied Therapeutics noise-free hype analysis.
Applied Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Applied earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Applied Therapeutics that are available to investors today. That information is available publicly through Applied media outlets and privately through word of mouth or via Applied internal channels. However, regardless of the origin, that massive amount of Applied data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Applied Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Applied Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Applied Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Applied Therapeutics alpha.

Applied Largest EPS Surprises

Earnings surprises can significantly impact Applied Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-09
2022-09-30-0.48-0.40.0816 
2024-03-06
2023-12-31-0.23-0.34-0.1147 
2023-08-10
2023-06-30-0.26-0.37-0.1142 
2019-08-12
2019-06-30-0.49-0.6-0.1122 
2023-05-11
2023-03-31-0.31-0.180.1341 
2021-08-12
2021-06-30-1.13-0.990.1412 
View All Earnings Estimates

Applied Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Applied Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
12th of March 2025
APPLIED THERAPEUTICS Earnings Preview Recent APLT Insider Trading, Hedge Fund Activity, an...
at news.google.com 
Google News at Macroaxis
6th of March 2025
Applied therapeutics COO Constantine Chinoporos sells 196 in stock - Investing.com
at news.google.com 
Macroaxis News: globenewswire.com
18th of February 2025
Applied Therapeutics, Inc. Sued for Securities Law Violations Investors Should Contact Lev...
at globenewswire.com 
Macroaxis News: globenewswire.com
14th of February 2025
APLT DEADLINE NOTICE ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics...
at globenewswire.com 
Macroaxis News: globenewswire.com
12th of February 2025
APLT CLASS ACTION REPORT Applied Therapeutics is being Sued for Securities Fraud Investors...
at globenewswire.com 
Macroaxis News: globenewswire.com
7th of February 2025
Levi Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in A...
at globenewswire.com 
Gurufocus Stories at Macroaxis
4th of February 2025
Levi Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. ...
at gurufocus.com 

Applied Therapeutics Investors Sentiment

The influence of Applied Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Applied. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Applied Therapeutics' public news can be used to forecast risks associated with an investment in Applied. The trend in average sentiment can be used to explain how an investor holding Applied can time the market purely based on public headlines and social activities around Applied Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Applied Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Applied Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Applied Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Applied Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Applied Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Applied Therapeutics' short interest history, or implied volatility extrapolated from Applied Therapeutics options trading.

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.